SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood (HOOD) is trending following a mixed earnings report that saw an EPS beat offset by a revenue miss, largely due to a decline in cryptocurrency trading. Community sentiment is polarized between concerns over valuation and crypto's impact, and optimism surrounding record annual performance, strong subscriber growth, new prediction markets, and a significant share buyback program.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan Green in 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is trending following mixed quarterly earningsan EPS beat, largely attributed to a one-time tax benefit, contrasted with a revenue miss and soft guidancewhich led to a significant sell-off despite a new $1 billion share buyback. Community discussion is sharply polarized between those buying the dip on growth and future autonomous vehicle potential, and others emphasizing persistent competitive pressures and the increasing perceived threat of robotaxis.

Mattel, Inc. engages in the ownership of children's and family entertainment franchises. It operates through the following segments: North America, International, and American Girl. The North America and International segments focus on marketing and selling toys and consumer products. The American Girl segment includes marketing, retailing, and publishing dedicated to its mission to help girls grow up with confidence and character. The company was founded by Elliot Handler, Ruth Handler, and Harold Matson in 1945 and is headquartered in El Segundo, CA.

Mattel, Inc.

Mattel is experiencing a dramatic sell-off after missing Q4 earnings expectations and providing a weaker 2026 profit outlook, with the stock recently hitting a 52-week high before plummeting. The community is sharply divided, with many debating if the steep decline is an overreaction and looking to buy the dip, while others anticipate further downside.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is trending as its recent Q4 earnings and Q1 guidance, while exceeding expectations, prompted a "sell the news" reaction, fueling community debate over its high valuation and characteristic volatility. Despite this, its integral role in AI infrastructure connectivity and a new warrant deal with Amazon tied to future purchases lead many to view the dip as a strategic buying opportunity.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart is trending following its robust Q4 earnings report, which exceeded revenue and EPS expectations and included optimistic long-term growth targets and a planned CEO transition. While many investors are bullish on the AI lending platform's performance and potential for a short squeeze, the stock's tempered price reaction in a challenging fintech sector has fueled widespread market confusion and debate.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is trending after its robust Q4 earnings and strong revenue guidance, which has spurred community discussion on its increasing importance as a core infrastructure provider for the "agentic internet" and AI workloads. Sentiment is highly positive, with many viewing the company as a top beneficiary in the AI era.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending due to groundbreaking five-year data from its personalized cancer vaccine trial with Merck, showcasing the potential of its mRNA platform in oncology; however, the stock faces significant volatility and community discussion following the FDA's refusal to review its influenza vaccine and ongoing patent litigation.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending after reporting weaker recent earnings and significant losses in its electric vehicle division, but strong future profit guidance and a strategic pivot to hybrids are driving positive investor sentiment and a perceived "margin-rebuild" narrative. This has sparked mixed community reactions and ongoing discussion around broader auto sector challenges with EV profitability.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as the community actively discusses how the FDA's refusal to review Moderna's influenza vaccine significantly enhances the market potential and value of Novavax's protein-based vaccine pipeline and its Matrix-M adjuvant technology. This fuels anticipation for new partnerships and intensified calls for management accountability amidst persistent short interest.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia Technologies is trending following its recent earnings report, which, despite showing strong revenue growth and significantly reduced cash burn, saw a "sell the news" reaction due to a larger-than-expected loss and a revised profitability timeline. The community is actively debating whether the sharp sell-off presents a buying opportunity, with bulls emphasizing improving fundamentals and bullish analyst coverage positioning Jumia as a key player in Africa's rapidly developing e-commerce market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Likely ETF Winners & Losers From Winter Storm Fern

Winter Storm Fern rattles the United States, lifting heating demand and natural gas prices as UNG stands out while airlines and consumers face headwinds.

<ul class="summary-bullets"><li>Oppenheimer downgraded Mosaic to ‘Perform’ from ‘Outperform’.</li><li>Tight sulfur market conditions are expected to persist into the first half of 2026, continuing to weigh on Mosaic’s outlook, the brokerage firm added.</li><li>Tight credit and increased competition due to an influx of lower-grade phosphate imports from China weighed on demand and margins in Brazil.</li></ul>Mosaic Company (MOS) shares were trading down 4.5% on Friday after the firm said that fertilizer market conditions remained challenging in the fourth quarter (Q4) of 2025, as weaker-than-usual seasonal demand weighed on results.In response, Oppenheimer downgraded Mosaic to ‘Perform’ from ‘Outperform’ and removed the firm’s previous $35 price target following the company’s “weak” preliminary Q4 results.Oppenheimer expects Mosaic to continue making gradual progress on operating rates, but noted there is no clear catalyst to lift fertilizer demand in the current crop year. Tight sulfur market conditions are also expected to persist into the first half of 2026, continuing to weigh on the outlook.Despite the intraday drop, retail sentiment on Stocktwits remained in the ‘bullish’ zone over the past 24 hours.<h2 class="st-heading-2">Q4 Preliminary Update</h2>In North America, fertilizer demand dropped sharply as growers remained under economic pressure and an early winter shortened the fall application season. Phosphates were hit hardest due to lower affordability than potash, with shipments estimated to be down about 20% from a year ago.The weak environment weighed on Mosaic’s results, with Q4 phosphate sales of about 1.3 million tonnes and potash sales near 2.2 million tonnes. In response, the company adjusted its phosphate production and shifted volumes to markets showing stronger demand, keeping overall output in line with the prior quarter, though lower sales and rising inventories pressured cash flow.Conditions in Brazil also worsened, as tighter credit and increased competition, due to an influx of lower-grade phosphate imports from China, weighed on demand and margins. As a result, Mosaic Fertilizantes’ sales fell short of expectations, even as full-year volumes were roughly flat.Looking ahead, Mosaic sees a more favorable setup in 2026, supported by nutrient replenishment needs, government support programs, tightening phosphate markets, and reduced Chinese exports, all of which could help lift demand and prices over time, it said.The company is expected to post its Q4 2025 results on February 24.Over the past year, <a href="https://stocktwits.com/symbol/MOS">MOS stock</a> has declined nearly 2%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-abus-stock-fall-today/cmUlzXeR4BY">ABUS Stock On Track For Biggest Intraday Drop In Over 5 Years – What’s The Issue Around Its Patent In Europe?</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Mosaic Company logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

MOS Stock Sees Red As Cheaper Chinese Imports Weigh On Q4 Operations

Mosaic Company said that fertilizer market conditions remained challenging in the fourth quarter, as weaker-than-usual seasonal demand weighed on results.

Equity

Mosaic Company said that fertilizer market conditions remained challenging in the fourth quarter, as weaker-than-usual seasonal demand weighed on results.


3 Basic Materials Funds to Buy as Cyclical Tailwinds Build

FSDPX, FKRCX and ACGGX stand out as materials funds as cyclical tailwinds, pricing power and commodity demand point to a stronger 2026.

Should You Invest in the State Street Materials Select Sector SPDR ETF (XLB)?

Top-Ranked ETFs to Power Your Portfolio Higher 

With market tailwinds building and optimism returning, these top-ranked ETFs can help investors capture momentum safely.

Notable ETF Outflow Detected - XLB, NEM, ECL, NUE

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Materials Select Sector SPDR Fund (Symbol: XLB) where we have...

Noteworthy ETF Outflows: XLB, ECL, MLM, FCX

See Which Of The Latest 13F Filers Holds XLY

At Holdings Channel, we have reviewed the latest batch of the 20 most recent 13F filings for the 09/30/2025 reporting period, and noticed that The Materials Select Sector SPDR Fund (Symbol: XLY) was...

US Food and Drug Administration Commissioner Marty Makary said he’s “taking a hard look” at whether Sarepta Therapeutics’ gene therapy, Elevidys, should remain on the market, following recent patient deaths involving the treatment.&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="http://stockwits.com/symbol/SRPT">Sarepta’s stock</a> plummeted more than 26% in midday trade on Friday. However, on Stocktwits, retail sentiment around the company remained in ‘extremely bullish’ territory amid ‘extremely high’ levels of chatter.A separate&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-request-sarepta-stop-all-shipments-gene-therapy-elevidys-source-says-2025-07-18/#:~:text=The%20FDA's%20request%20follows%20the,condition%20called%20Duchenne%20muscular%20dystrophy.">report</a> by Reuters said that the FDA plans to request Sarepta to stop all shipments of Elevidys voluntarily.Makary’s comments during an&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-07-18/fda-is-investigating-if-sarepta-s-elevidys-should-stay-on-market">interview</a> with Bloomberg come after the company on Thursday disclosed a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sarepta-draws-wall-street-ire-after-third-patient-death-this-year/ch8kMF7R5qY">third patient death</a> in a clinical trial involving a different experimental gene therapy that uses a similar viral delivery system.&nbsp;A company spokesperson&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-07-18/sarepta-says-another-patient-died-after-receiving-gene-therapy">told</a> Bloomberg that a 51-year-old patient died of acute liver failure last month in an early-stage trial of a gene therapy to treat limb-girdle muscular dystrophy.The FDA had already been investigating two earlier deaths linked to Elevidys.The growing number of fatalities is raising questions about the future of Sarepta’s therapies and the regulatory path for gene treatments that use adeno-associated viral (AAV) vectors. Elevidys, which was granted accelerated approval in 2023 for Duchenne muscular dystrophy, has remained on the market under post-approval study requirements.Bloomberg also reported that the latest death resulted in an unusually tense exchange between analysts and Sarepta executives on a Friday call. The same group of analysts reportedly had a call with the company earlier this week about the future of Elevidys, but the firm failed to disclose the third patient death. On Friday, two of the analysts asked executives whether the company was keeping any other fatalities undisclosed.“We are historically a very transparent organization,” said Sarepta CEO Douglas Ingram, according to the report, adding that the company didn’t disclose the third patient death earlier because “it was neither material nor central” to what was being discussed.&nbsp;Sarepta’s stock is down 88% year-to-date and nearly 90% over the past 12 months.Get updates to this developing story directly on Stocktwits.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/grubhub-owner-wonder-reportedly-in-talks-for-500-m-debt-refinancing/ch8kHoKR5qp">Grubhub Owner Wonder Reportedly In Talks For $500M Debt Refinancing</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Sarepta Therapeutics logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

FDA Is Reportedly ‘Taking A Hard Look’ To Evaluate Whether Sarepta’s Gene Therapy Elevidys Should Remain On The Market

The FDA had already been investigating two earlier deaths linked to Elevidys.

President Donald Trump’s confirmation of a 50% tariff on copper imports sent U.S. copper futures and mining stocks – including Freeport-McMoran (FCX) and Southern Copper (SCCO) – sharply higher Tuesday. He also said that tariffs targeting the pharmaceutical and semiconductor sectors would be next on the docket.“We’re going to be announcing pharmaceuticals, chips, and various couple of other things — big one,” Trump told reporters at a White House cabinet meeting. “Now today we’re doing copper… I believe the tariff on copper, we’re going to make it 50%.”U.S. copper futures jumped more than 10% on the news, while&nbsp;<a href="http://stocktwits.com/symbol/FCX">Freeport-McMoran’s stock</a> rallied nearly 5%. On Stocktwits, retail sentiment around Freeport-McMoRan edged higher within ‘bullish’ territory as chatter jumped to ‘high’ levels from ‘normal’ a day ago.&nbsp;<a href="http://stocktwits.com/symbol/SCCO">Southern Copper’s stock</a> also gained more than 1% following the announcement, and&nbsp;In February, the Trump administration launched a Section 232 investigation into copper imports, citing potential national security concerns. That probe is due to conclude by November.During the cabinet meeting, Agriculture Secretary Brooke Rollins also raised alarms about Chinese ownership of U.S. farmland, calling it a “massive national security issue.”&nbsp;She said China has been acquiring land near U.S. military bases and urged Congress to ban such purchases. “There’s an executive order coming and some other things coming behind that,” she added.Despite the tough stance on trade and foreign investment, Trump said U.S.-China relations remain stable. “They’ve been very fair on our trade deal, honestly,” he said, adding that he maintains regular communication with Chinese President Xi Jinping. “I’m getting along with President Xi very well. We speak often.”Markets remained mixed after Trump’s cabinet meeting. The&nbsp;<a href="http://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a> edged 0.05% higher, while the&nbsp;<a href="http://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Index ETF (DIA)</a> remained down by 0.27%. Meanwhile, the&nbsp;<a href="http://stocktwits.com/symbol/QQQ">Invesco QQQ Trust Series 1 (QQQ)</a>, which tracks the tech-heavy Nasdaq 100, gained 0.2%.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-says-eu-trade-deal-two-days-off-predicts-300-b-tariff-revenue/chFvyNrR5WM">Trump Says EU Trade Deal ‘Two Days Off’, Predicts $300B In Tariff Revenue By Year-End</a>

U.S. President Donald Trump speaks to members of the press during a Cabinet Meeting at the White House on July 08, 2025 in Washington, DC. (Photo by Andrew Harnik/Getty Images)

Copper Prices Surge After Trump Says 50% Tariff Is Coming – Pharma And Chip Levies Next

President Donald Trump also said U.S.-China relations remain stable and that he’s getting along with Chinese President Xi Jinping “very well.” 

SSgA Active Trust - State Street Materials Select Sector SPDR ETF

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $SHOP earnings on Wednesday?

XLB
Materials Select Sector SPDR Fund

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest XLB News

XLBMaterials Select Sector SPDR Fund